Filtros de búsqueda

Lista de obras de Sandra M. Swain

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

artículo científico publicado en 2017

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).

artículo científico publicado en 2016

8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer

artículo científico publicado en 1986

A Novel Case of Bisphosphonate-Related Osteonecrosis of the Torus Palatinus in a Patient with Metastatic Breast Cancer

artículo científico publicado en 2006

A Passion for Solving the Puzzle of Cancer: Jane Cooke Wright, M.D., 1919-2013

A Phase II Trial with Trastuzumab and Pertuzumab in Patients with HER2-Overexpressed Locally Advanced and Metastatic Breast Cancer

Breast cancer trial article

A Step in the Right Direction

artículo científico publicado en 2006

A critical review of the enrollment of black patients in cancer clinical trials

artículo científico

A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer

artículo científico publicado en 2007

A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer

artículo científico publicado en 2004

A phase II trial of paclitaxel (Taxol�) as first line treatment in advanced breast cancer

artículo científico publicado en 1995

A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials.

artículo científico publicado en 2012

A pilot study to evaluate the vascular endothelial growth factor receptor tyrosine kinase inhibitor AZD2171 and chemotherapy in locally advanced and inflammatory breast cancer

artículo científico publicado en 2005

A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

artículo científico publicado en 2006

ASCO's approach to a learning health care system in oncology.

artículo científico publicado en 2013

Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel

artículo científico publicado en 2013

Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway

artículo científico publicado en 2020

Adjuvant chemotherapy for breast cancer: an update.

artículo científico publicado en 2001

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

artículo científico publicado en 2012

Adjuvant therapy in early breast cancer

artículo científico publicado el 1 de agosto de 1991

Adult multicenter trials using dexrazoxane to protect against cardiac toxicity

artículo científico publicado en 1998

Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer

artículo científico publicado en 2010

Amenorrhea from Breast Cancer Therapy — Not a Matter of Dose

artículo científico publicado en 2010

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

artículo científico publicado en 2006

Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.

artículo científico publicado en 2008

Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).

artículo científico publicado en 2017

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer

artículo científico publicado en 2006

Aromatase inhibitors--a triumph of translational oncology

artículo científico publicado en 2005

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

artículo científico publicado en 2014

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre

artículo científico publicado en 2005

Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia

artículo científico publicado en 2013

Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial.

artículo científico publicado en 2017

Autocrine and paracrine growth regulation of human breast cancer

artículo científico publicado en 1986

Avastin withdrawal symptoms

artículo científico publicado en 2012

Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs

scientific article published on 26 November 2019

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

article by Harry D. Bear et al published March 2013 in Obstetrical and Gynecological Survey

Bevacizumab added to neoadjuvant chemotherapy for breast cancer

artículo científico publicado en 2012

Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS metastases: the Road less Travelled

artículo científico publicado en 2013

Bevacizumab and Heart Failure Risk in Patients With Breast Cancer: A Thorn in the Side?

artículo científico publicado en 2011

Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer.

artículo científico publicado en 2014

Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38.

artículo científico publicado en 2015

Building bridges to conquer cancer

artículo científico publicado en 2013

CA 125 elevation in breast cancer: a case report and review of the literature.

artículo científico publicado en 2004

CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities

artículo científico publicado en 2018

CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancer

artículo científico publicado en 2010

Ca(2+)/calmodulin regulates Kvβ1.1-mediated inactivation of voltage-gated K(+) channels

artículo científico publicado en 2015

Can we increase survival in breast cancer with innovative applications of conventional drugs?

artículo científico publicado en 1994

Cardiac Protection in HER2-Targeted Treatment: How Should We Measure New Strategies?

artículo científico publicado en 2016

Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines

artículo científico publicado en 2016

Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study

artículo científico publicado en 2013

Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer

artículo científico publicado en 2008

Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.

artículo científico publicado en 2008

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

artículo científico publicado en 1997

Cardiovascular complications of breast cancer therapy

scientific article published on 01 April 2008

Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs

artículo científico publicado en 2018

Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone.

artículo científico publicado en 2006

Chemotherapy: Updates and New Perspectives ⬇️

artículo científico publicado el 1 de enero de 2010

Circulating biomarkers of bevacizumab activity in patients with breast cancer

artículo científico publicado en 2007

Clinical breast cancer research core

artículo científico publicado en 1994

Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa

artículo científico publicado en 2019

Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.

artículo científico publicado en 2011

Contralateral Breast Cancer: Where Does It All Begin?

artículo científico publicado en 2005

Controversies in the treatment of cancer of the breast

artículo científico publicado en 1987

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].

artículo científico publicado en 2017

Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial

artículo científico publicado en 2013

Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer.

artículo científico publicado en 2000

Detectable Inhibition of Heparin-Binding Growth Factor Activity in Sera From Patients Treated With Pentosan Polysulfate

artículo científico publicado en 1993

Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR).

artículo científico publicado en 2005

Does CDKN2A loss predict palbociclib benefit?

artículo científico publicado en 2015

Drug discount program

artículo científico publicado en 2013

Ductal Carcinoma in Situ

artículo científico publicado en 1992

Ductal carcinoma in situ, complexities and challenges.

artículo científico publicado en 2004

EARLY FLOWERING3 Regulates Flowering in Spring Barley by Mediating Gibberellin Production and FLOWERING LOCUS T Expression

scientific article published on 29 April 2014

Effect of docetaxel duration on clinical outcomes: exploratory analysis of CLEOPATRA, a phase III randomized controlled trial.

artículo científico publicado en 2017

Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned?

artículo científico publicado en 2016

Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II T

artículo científico publicado en 2016

Erratum to “NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors”.

artículo científico publicado en 2014

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

artículo científico publicado en 2017

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

artículo científico publicado en 2004

Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor

artículo científico publicado en 2004

Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer

artículo científico publicado en 2012

Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray

artículo científico

First, do no harm.

artículo científico publicado en 2008

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

artículo científico publicado en 1989

Focus on You: Cancer clinical trials perspectives.

artículo científico publicado en 2016

Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer

artículo científico

Gene expression patterns and profile changes pre- and post-erlotinib treatment in patients with metastatic breast cancer

artículo científico

Gene expression profile and angiogenic marker correlates with response to neoadjuvant bevacizumab followed by bevacizumab plus chemotherapy in breast cancer

artículo científico publicado en 2008

Genetic Analysis of Gibberellin Signal Transduction

scientific article published on 01 September 1996

Genomic profiling of breast cancer in African-American women using MammaPrint.

artículo científico publicado en 2016

HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens

artículo científico publicado en 2016

Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer

artículo científico publicado en 2013

Heparin-binding growth factor blockade with pentosan polysulfate

scientific article published on 01 November 1993

Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.

artículo científico publicado en 1989

Hormonal manipulation in the adjuvant treatment of breast cancer

artículo científico publicado en 1993

Hormone replacement therapy in women with a history of breast carcinoma

artículo científico publicado en 1994

IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer

scientific article published on 12 April 2019

Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.

artículo científico publicado en 2013

Improving Documentation of Pain Management at MedStar Washington Cancer Institute

artículo científico publicado en 2015

In Situ or Localized Breast Cancer -- How Much Treatment Is Needed?

artículo científico publicado en 1993

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab.

artículo científico publicado en 2018

Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA.

artículo científico publicado en 2014

Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--initial experience.

artículo científico publicado en 2007

Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel

artículo científico publicado en 2006

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

artículo científico publicado en 2010

Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial

artículo científico publicado en 2015

Ixabepilone for the treatment of solid tumors: a review of clinical data

artículo científico publicado en 2008

Ixabepilone: clinical role in metastatic breast cancer

artículo científico publicado en 2011

Lactic Acidosis in Lymphoma: Prompt Resolution of Acidosis With Therapy Directed at the Lymphoma

scientific article published on 01 September 1988

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial

artículo científico publicado en 2013

Left Ventricular Ejection Fraction Monitoring Adherence Rates: Why So Low?

scientific article published on 01 August 2018

Liquid-chromatographic determination of erlotinib (OSI-774), an epidermal growth factor receptor tyrosine kinase inhibitor

artículo científico publicado en 2003

Locally Advanced and Inflammatory Breast Cancer

artículo científico publicado en 2008

Locally advanced breast cancer

artículo científico publicado en 1989

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Pa

artículo científico publicado en 2017

Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.

artículo científico publicado en 2018

Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy

artículo científico publicado en 2004

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

artículo científico publicado en 2011

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer

artículo científico publicado en 2010

Luminal A Breast Cancer and Molecular Assays: A Review

article

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial

artículo científico publicado en 2011

Meta-analysis: should it be more than the sum of its parts?

artículo científico publicado en 2010

Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.

artículo científico

Mitoxantrone, 5-fu, and leucovorin in breast cancer

artículo científico publicado en 1994

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy

artículo científico publicado en 2008

NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors

artículo científico publicado en 2013

NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response

scientific article published on 05 May 2020

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2 ⬇️

artículo científico publicado en 2019

Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer

artículo científico publicado en 1987

Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer

artículo científico publicado en 2005

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial

artículo científico publicado en 2015

Noninvasive breast cancer: Part 1. Ductal carcinoma in situ--incidence, presentation, guidelines to treatment

artículo científico publicado en 1989

Noninvasive breast cancer: Part 2. Lobular carcinoma in situ--incidence, presentation, guidelines to treatment.

artículo científico publicado en 1989

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.

artículo científico publicado en 2009

Ongoing adjuvant trials with trastuzumab in breast cancer.

artículo científico publicado en 2003

Oophorectomy in carriers of BRCA mutations.

artículo científico publicado en 2002

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.

artículo científico publicado en 2012

Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination

artículo científico publicado en 2019

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

artículo científico publicado en 2014

Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia.

artículo científico publicado en 2012

Pazopanib for the treatment of breast cancer

artículo científico publicado en 2012

Peripheral neuropathy induced by microtubule-stabilizing agents.

artículo científico publicado en 2006

Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer

artículo científico

Pertuzumab for the treatment of breast cancer

artículo científico publicado en 2014

Pertuzumab for the treatment of breast cancer: a safety review

artículo científico publicado en 2016

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

artículo científico publicado en 2012

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

artículo científico publicado en 2013

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

scientific article published on 12 March 2020

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

artículo científico publicado en 2015

Pertuzumab: increasing the options.

artículo científico publicado en 2014

Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms

artículo científico publicado en 2002

Phase I trial of dasatinib and ixabepilone in patients with solid tumors

artículo científico publicado en 2012

Phase I trial of pentosan polysulfate.

artículo científico publicado en 1995

Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer

artículo científico publicado en 2004

Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes

artículo científico publicado en 2007

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer

artículo científico publicado en 2005

Phase II study of oral etoposide for patients with advanced breast cancer.

artículo científico publicado en 1995

Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer

artículo científico publicado en 2006

Ppd-1 is a key regulator of inflorescence architecture and paired spikelet development in wheat

artículo científico publicado en 2015

Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.

artículo científico publicado en 2013

Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer

scientific article published on 31 August 2020

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study.

artículo científico publicado en 2019

Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age.

artículo científico publicado en 2015

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells

artículo científico publicado en 2003

Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancer.

artículo científico publicado en 2004

Reimbursement for Solid Tumor Autologous Bone Marrow Transplantation Trials: A Strategy for Ensuring Continuation of a Promising Therapy

artículo científico publicado en 1991

Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility

artículo científico publicado en 1993

Reply to E.J. Moylan et al.

artículo científico publicado en 2014

Reply to a. Avan et Al.

artículo científico publicado en 2015

Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014)

artículo científico publicado en 2014

Results of concomitantly administered chemoradiation for locally advanced noninflammatory breast cancer

scientific article published on 01 October 1994

Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy.

artículo científico publicado en 2002

SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function.

artículo científico publicado en 2017

Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA.

artículo científico publicado en 2014

Salvage treatment with intermediate-dose methotrexate and 5-fluorouracil in metastatic breast cancer

artículo científico publicado en 1988

Selection of therapy for stage III breast cancer

artículo científico

Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epider

artículo científico publicado en 2012

Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer

scientific article published on 01 August 2019

Systemic therapy of locally advanced breast cancer: review and guidelines

artículo científico publicado en 1989

Take care of your neighborhood

artículo científico publicado en 2017

Tamoxifen and contralateral breast cancer: the other side

artículo científico publicado en 2001

Tamoxifen and fluoxymesterone versus tamoxifen and danazol in metastatic breast cancer--a randomized study

artículo científico publicado en 1988

Tamoxifen for patients with estrogen receptor-negative breast cancer.

artículo científico publicado en 2001

Tamoxifen: the Long and Short of It

artículo científico publicado en 1996

The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.

artículo científico publicado en 2016

The Heart of the Matter

artículo científico publicado en 2007

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer

artículo científico publicado en 2014

The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl

artículo científico publicado en 2016

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review.

artículo científico publicado en 2003

The effect of systemic therapy on local-regional control in locally advanced breast cancer ⬇️

artículo científico publicado el 1 de enero de 1992

The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue

artículo científico publicado en 1990

The impact of systemic therapy following ductal carcinoma in situ.

artículo científico publicado en 2010

The influence of a gene expression profile on breast cancer decisions

artículo científico publicado en 2009

The role of primary chemotherapy in early breast cancer.

artículo científico publicado en 1996

The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.

artículo científico publicado en 1988

The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profiling

artículo científico publicado en 2021

Therapy of patients with metastatic breast cancer with 5-fluorouracil, leucovorin and carboplatin.

artículo científico publicado en 1992

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

artículo científico publicado en 2014

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

artículo científico publicado en 2005

Treatment of HER2-positive metastatic breast cancer

artículo científico publicado en 2015

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA).

artículo científico publicado en 2013

Treatment of patients with inflammatory breast cancer

artículo científico publicado en 1989

Treatment of stage III breast cancer. A panel discussion

artículo científico publicado en 1989

Tumor markers: should we or shouldn't we?

scientific article published on 01 May 2001

Twenty-five year results of the national cancer institute randomized breast conservation trial

artículo científico publicado en 2011

Upholding the Affordable Care Act—implications for oncology

artículo científico publicado en 2012

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 30 November 2018

Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831

artículo científico publicado en 2020

Video intervention increases participation of black breast cancer patients in therapeutic trials

artículo científico publicado en 2017

Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study.

artículo científico publicado en 2014

What currently defines a breast center? Initial data from the national accreditation program for breast centers.

artículo científico publicado en 2013

p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancer

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda